Isolation and expansion of oligodendrocyte progenitor cells from cryopreserved human umbilical cord blood

References

• Escolar ML, Poe MD, Provenzale JM, Richards KC, Allison J, Wood S, . Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005;352:2069–81.
   PubMed Web of Science ®Google Scholar
• Gomez CM, Muggleton-Harris AL, Whittingham DG, Hood LE, Readhead C. Rapid preimplantation detection of mutant (shiverer) and normal alleles of the mouse myelin basic protein gene allowing selective implantation and birth of live young. Proc Natl Acad Sci USA. 1990; 87:4481–4.
   PubMed Web of Science ®Google Scholar
• Liu S, Qu Y, Stewart TJ, Howard MJ, Chakrabortty S, Holekamp TF, McDonald JW. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci USA. 2000; 97:6126–31.
   PubMed Web of Science ®Google Scholar
• Nistor GI, Totoiu MO, Haque N, Carpenter MK, Keirstead HS. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia. 2005;49 385–96.
   PubMed Web of Science ®Google Scholar
• Windrem MS, Schanz SJ, Guo M, Tian GF, Washco V, Stanwood N, . Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Cell Stem Cell. 2008;2:553–65.
   PubMed Web of Science ®Google Scholar
• Givogri MI, Galbiati F, Fasano S, Amadio S, Perani L, Superchi D, . Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy. J Neurosci. 2006; 26:3109–19.
   PubMed Web of Science ®Google Scholar
• Pellegatta S, Tunici P, Poliani PL, Dolcetta D, Cajola L, Colombelli C, . The therapeutic potential of neural stem/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage/microglia activation. Neurobiol Dis. 2006;21:314–23.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Sanberg CD, Kuzmin-Nichols N, Willing AE, Gemma C, Bickford PC, . Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS ONE. 2008;3:e2494.
   PubMed Web of Science ®Google Scholar
• Kurtzberg J, Kosaras B, Stephens C, Snyder EY. Umbilical cord blood cells engraft and differentiate into neural tissue after human transplantation. Biol Blood Marrow Transplant. 2003;9:128.
   Google Scholar
• Goldman SA, Schanz S, Windrem MS. Stem cell-based strategies for treating pediatric disorders of myelin. Hum Mol Genet. 2008;17:R76–83.
   Web of Science ®Google Scholar
• Keirstead HS. Stem cell transplantation into the central nervous system and the control of differentiation. J Neurosci Res. 2001;63:233–6.
   PubMed Web of Science ®Google Scholar
• Keirstead HS. Stem cells for the treatment of myelin loss. Trends Neurosci. 2005;28:677–83.
   PubMed Web of Science ®Google Scholar
• Brüstle O, Jones KN, Learish RD, Karram K, Choudhary K, Wiestler OD, . Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science. 1999;285: 754–6.
   PubMed Web of Science ®Google Scholar
• Galli R, Gritti A, Bonfanti L, Vescovi AL. Neural stem cells: an overview. Circ Res. 2003;92:598–608.
   PubMed Web of Science ®Google Scholar
• Kang SH, Bergles DE. Glial progenitor cells in the adult brain reveal their alternate fate. Nat Neurosci. 2008; 11:1365–7.
   PubMed Web of Science ®Google Scholar
• Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R, Trakhtenbrot L. Donor derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009;17: 222–230.
   Google Scholar
• Tracy E, Aldrink J, Panosian J, Beam D, Thacker J, Reese M, Kurtzberg J. Isolation of oligodendrocyte-like cells from human umbilical cord blood. Cytotherapy. 2008;10: 518–25.
   PubMed Web of Science ®Google Scholar
• Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, . Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA. 1995; 92:10119–22.
   PubMed Web of Science ®Google Scholar
• Back SA, Volpe JJ. Approaches to the study of disease involving oligodendroglial death. Koliastsos V, Ratan R. Cell Death and Diseases of the Nervous System. Totowa: Humana Press, 1999 401–28.
   Google Scholar
• Zeigler F, Hall SG. Isolation of oligodendroglial cells from cultured neural stem/progenitors. Methods Mol Biol. 2007; 407:323–31
   PubMedGoogle Scholar
• Mokrý J, Karbanová J, Filip S, Cízková D, Pazour J, English D. Phenotypic and morphological characterization of in vitro oligodendrogliogenesis. Stem Cells Dev. 2008;17: 333–41.
   PubMed Web of Science ®Google Scholar
• Nicolay DJ, Doucette JR, Nazarali AJ. Transcriptional control of oligodendrogenesis. Glia. 2007;55:1287–99.
   PubMed Web of Science ®Google Scholar
• Marty MC, Alliot F, Rutin J, Fritz R, Trisler D, Pessac B. The myelin basic protein gene is expressed in differentiated blood cell lineages and in hemopoietic progenitors. Proc Natl Acad Sci USA. 2002;99: 8856–61.
   PubMed Web of Science ®Google Scholar
• Lee MW, Moon YJ, Yang MS, Kim SK, Jang IK . Neural differentiation of novel multipotent progenitor cells from cryopreserved human umbilical cord blood. Biochem Biophys Res Commun. 2007; 358:637–43.
   PubMed Web of Science ®Google Scholar
• Sharp J, Keirstead HS. Therapeutic applications of oligodendrocyte precursors derived from human embryonic stem cells. Curr Opin Biotechnol. 2007;18:434–40.
   PubMed Web of Science ®Google Scholar
• Arien-Zakay H, Lazarovici P, Nagler A. Tissue regeneration potential in umbilical cord blood. Best Prac Res Clin Hematol. 2010;23:291–303.
   PubMed Web of Science ®Google Scholar